Inflammatory Bowel Disease Alert Sample


Alert Sample

Alert results for: Inflammatory Bowel Disease

Information between 27th July 2024 - 5th October 2024

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Select Committee Documents
Tuesday 3rd September 2024
Written Evidence - AstraZeneca
ENB0044 - Engineering biology

Engineering biology - Science and Technology Committee

Found: Inflammatory Bowel Disease) and how such diseases influence drug absorption and delivery.



Parliamentary Research
Reducing plastic waste - POST-PN-0724
Jul. 31 2024

Found: Science & Technology revealed that microplastics were 50% more prevalent in faeces of humans with inflammatory



Non-Departmental Publications - Transparency
Jul. 30 2024
Commission on Human Medicines
Source Page: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2023
Document: (PDF)
Transparency

Found: University of Edinburgh Shahida Din GRID Additional British Society of Gastroenterolog y, Inflammatory



Non-Departmental Publications - Statistics
Jul. 30 2024
Government Office for Science
Source Page: Microbiome manipulation
Document: (PDF)
Statistics

Found: There are ongoing clinical trials in the UK using FMT to treat liver disease, inflammatory bowel disease



Arms Length Bodies Publications
Aug. 22 2024
NICE
Source Page: Risankizumab for treating moderately to severely active ulcerative colitis
Publication Type: Supporting evidence
Document: Committee papers (PDF 4.64 MB) (webpage)
Published

Found: How to predict clinical relapse in inflammatory bowel disease patients.

Aug. 08 2024
NICE
Source Page: PillCam COLON 2 for investigation of the colon through direct visualisation
Publication Type: Scope published
Document: Final protocol PDF 362 KB (webpage)
In development

Found: family history, genetic conditions such as Familial Adenomatous Polyposis (FAP) and Lynch syndrome, inflammatory

Jul. 30 2024
NICE
Source Page: Maternal and child nutrition
Publication Type: Draft guidance consultation
Document: Evidence review: O PDF 9 MB (webpage)
In consultation

Found: requiring specific diets due to chronic diseases such as coeliac disease, food intolerances or allergies, inflammatory

Jul. 30 2024
NICE
Source Page: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238
Publication Type: Invitation to participate
Document: Final scope PDF 186 KB (webpage)
In development

Found: Inflammatory bowel disease (2015). NICE quality standard 81.

Jul. 30 2024
NICE
Source Page: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238
Publication Type: Invitation to participate
Document: Provisional stakeholder list (post-referral) PDF 169 KB (webpage)
In development

Found: Commentators (no right to submit or appeal) • NHS England Relevant research groups • Cochrane Inflammatory

Jul. 30 2024
NICE
Source Page: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238
Publication Type: Invitation to participate
Document: Equality impact assessment (scoping) PDF 129 KB (webpage)
In development

Found: Yes, the company noted during consultation that inflammatory bowel disease may be classed as a disability

Jul. 30 2024
NICE
Source Page: Guselkumab for previously treated moderately to severely active Crohn's disease ID6238
Publication Type: Invitation to participate
Document: NICE's response to comments on the draft scope and provisional stakeholder list PDF 226 KB (webpage)
In development

Found: In line with recent appraisals in inflammatory bowel disease (TA888, TA905, TA925, TA956) and others

Jul. 09 2024
NHS England
Source Page: 2022/23 National Cost Collection Data Publication
Document: The National Schedule of NHS Costs 2022/23 (Excel)
Data and statistics

Found: - Inflammatory Bowel Disease with Single Intervention, with CC Score 0-347794199.0720067348.580000002

Jun. 12 2024
NICE
Source Page: Risankizumab for treating moderately to severely active ulcerative colitis
Publication Type: Final draft guidance
Document: Committee papers (PDF 4.63 MB) (webpage)
Published

Found: How to predict clinical relapse in inflammatory bowel disease patients.

Sep. 05 2023
NICE
Source Page: Risankizumab for treating moderately to severely active ulcerative colitis
Publication Type: Invitation to participate
Document: Final scope (PDF 197 KB) (webpage)
Published

Found: Background Ulcerative colitis is the most common inflammatory bowel disease.

Jun. 07 2023
NICE
Source Page: Risankizumab for treating moderately to severely active ulcerative colitis
Publication Type: Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6209
Document: Draft scope post referral (PDF 210 KB) (webpage)
Published

Found: Background Ulcerative colitis is the most common inflammatory bowel disease.




Inflammatory Bowel Disease mentioned in Scottish results


Scottish Cross Party Group Publications
Minute of Meeting for 18 September 2024 (PDF)
Source Page: Cross-Party Group in the Scottish Parliament on Inflammatory Bowel Disease
Published: 18th Sep 2024

Found: 1 Cross -Party Group on Inflammatory Bowel Disease (IBD) 18 September 2024, 6 -8pm Minute s

Agenda for the Meeting on 18 September 2024 (PDF)
Source Page: Cross-Party Group in the Scottish Parliament on Inflammatory Bowel Disease
Published: 18th Sep 2024

Found: 1 Cross -Party Group on Inflammatory Bowel Disease Annual General Meeting Wednesday 18th September

Minute of the Meeting on 13 December 2023 (PDF)
Source Page: Cross-Party Group in the Scottish Parliament on Inflammatory Bowel Disease
Published: 13th Dec 2023

Found: 1 Cross -Party Group on Inflammatory Bowel Disease 13th December 2023, 6pm Minute Present

Registration Form 2024 (PDF)
Source Page: Cross-Party Group in the Scottish Parliament on Inflammatory Bowel Disease

Found: CROSS -PARTY GROUP REGISTRATION FORM NAME OF CROSS -PARTY GROUP Cross -Party Group on Inflammatory

Annual Return 2023 to 2024 (PDF)
Source Page: Cross-Party Group in the Scottish Parliament on Inflammatory Bowel Disease

Found: Cross -Party Group Annual Return Name of Cross -Party Group Cross -Party Group on Inflammatory Bowel



Scottish Government Publications
Friday 16th August 2024
Digital Health and Care Directorate
Source Page: Records Management Code of Practice for Health and Social Care
Document: Records Management Code of Practice for Health and Social Care v4.0 (PDF)

Found: disease • Depression • Diabetes • Epilepsy • Heart Failure • Hepatitis • Hypertension • Inflammatory